Everyone loves a good bad guy. It seems to make complex issues easier to deal with when there is a scapegoat defined. Disease kills many people on a daily basis all around the world. However, many people view the big drug companies as evil profiteers in the fight against disease, wielding patents to protect their profits rather than wielding medicine to combat disease. Medicines have been created to combat disease which greatly improves survival outcomes and daily quality of life. Many of the large pharmaceutical companies are responsible for inventing and manufacturing a majority of the medications that have had this positive impact on society. Although it may seem that many view pharmaceutical companies as profiteering from illness via patents, people world-wide benefit from the process, especially when generic production is authorized. This would never happen without the current model utilizing pharmaceutical patents.
Patents give intellectual rights to a person or a group of people that invent something. Patents fuel innovation because they give a temporary monopoly to the inventor that received the patent. Otherwise, the originator of a product may not receive the credit, more specifically, the financial reward for creating something useful and sharing it with the world. This applies to medicine just as much as anything else. Pharmaceutical companies spend enormous amounts of time and treasure to research and develop new, effective and safe medications to
The pharmaceutical industry is one of the most powerful and greedy industries in our country, with a goal to make as large a profit as possible, at the expense of the sick.
Specify the types of country risks that pharmaceutical firms face in international business. How do the political and legal systems of countries affect the global pharmaceutical industry?
In the video Escape Fire, I was so flabbergasted by the numbers and health outcomes we as a society have let our nation become. One of the most heart-wrenching evidence is, even though our health care industry is so expensive our health outcomes are the worse. 75% of disabilities and dead’s are preventable, according to the film.
The high prices set by pharmaceutical companies for drugs allows the companies to continue researching, developing, and producing new drugs. As new diseases are discovered, new medications must be discovered in order to treat them.
Secondly, it reduces the time for patient’s evaluation. Due to DTC, drug companies are rarely encouraged to research and evaluate the effect of drugs on patients. The companies do not research enough to evaluate the side effects of drugs before the drug administration. This will cause crucial damages to patient’s health. Same is the case facing by PharmaCARE who had to face negative consequences of drugs because the company was having lack of research before administrating the drug. Due to direct marketing, patents do not feel the need for taking doctor opinion and take self-treatment which sometime cause risk to patients life.
Even though the pharmaceutical industry had been highly profitable and contributed about 40% OF Ciba-Geigy’s revenues in profit, there were some trends, which were worrying. The government had attempted to reduce a cost of healthcare thus; pressure to lower costs was mounting on industrialized countries. There were restrictions to introduce new products, and price control became stricter while limiting the freedom of doctors to prescribe medications. Patent controls were becoming reduced, and the pharmaceutical industry was becoming increasingly criticized. These trends later made the industry to
On september 2nd 2011, a Twenty-four year old man from cincinnati named Kyle Willis´ fell victim to the corruption of the pharmaceutical industry(Gann, Carrie). Willis had a severe toothache on his wisdom tooth that resulted in its extraction. After the surgery, Willis´s face started to swell and was sent to the emergency room. He was prescribed antibiotic medications and also painkillers in order to follow standard recovery procedure. Kyle Willis’ could not afford both drugs so he just purchased the pain killers because of the swellings unbearable pain. The infection continued to spread into his brain which lead to severe brain swelling and eventually Kyle Willis’ death. Kyle Willis’ died because he could not afford the medication that would have saved his life. There are many other people that can 't afford the drugs they need, which results them losing their lives. According to harvard studies, over 45,000 people annually die due to lack of health care coverage(Harvard Gazette). According to their studies, those who are privately insured have 40% chance less of dying than those who have insufficient funds(Harvard Gazette). The monopoly and corruption of the pharmaceutical industry is un-american and inhumane because it causes the middle class to not receive the help they need to recover.
While that could arguably lead to the rise of corporate drug companies, it's no different to the big pharmaceutical corporations like GlaxoSmithKlein, Pfizer and Bayer. It would boost America's already deplorable economy and lead to substantial regulation that would benefit everyone.
The Pharmaceutical industry has been in the spotlight for decades due to the fact that they have a reputation for being unethical in its marketing strategies. In The Washington Post Shannon Brownlee (2008) states, “We try never to forget that medicine is for the people. It is not for the profits. The profits follow.” This honorable statement is completely lost in today’s world of pharmaceutical marketing tactics. These tactics are often deceptive and biased. Big Pharma consistently forgets their moral purpose and focuses primarily on the almighty dollar. Big Pharma is working on restoring their reputation by reforming their ethical code of conduct.
First, it was initially was the physicians wanting to gain more control and autonomy in the medical field. Limiting the pharmacist or druggist ability to dispense medication only as prescribed by a physician limited the practice of pharmaceutical science to the drug manufacturers. The public played a role in causing the shift because the public was buying into the advertisements from the patent medicine makers and believing the “cure” that said medicine did. The public would use an advertisement instead of a physician visit to determine if the medication was right for
Even though the pharmaceutical industry has made great improvements to human health and quality of life, like creating drugs for the treatment of AIDS, cancer, and other diseases, an increasing tension is growing between the public and the industry. These thoughts are fueled by issues such as drug pricing, affordable health care, and the battle against epidemic diseases in third world countries; social critics wonder whether this multi-billion dollar industry is giving enough back to the community and fulfilling its social responsibility.
While this case is literally full of negative aspects, we will only focus on the main points for both arguments. Pharmaceutical companies want to be sure that the products they spend years and millions of dollars to create are not easily reproduced and sold at discount prices. The profits pharmaceuticals make of their patented products are supposed to refinance new research. So taking away their exclusive distribution rights and allowing other manufacturers to just copy the product and sell it at
Therefore, protection of patents is one of the key conditions necessary for further development of the pharmaceutical industry. At the same time, non-efficient legislation that does not provide the necessary level of patent protection is one of the factors that hamper expansion of “Big Pharmaceutical” companies to the developing countries8.
The concept of product patent for pharmaceutical products is likely to make life saving medicine beyond the reach of the poor and deprived section of the society around the world.
This enabled numerous “me too” drugs to achieve satisfactory returns on investment. Imitating a known drug reduced R&D risk considerably, while the marketplace was open to products offering minor advantages such as a more convenient dosage with fewer side effects, but with much the same therapeutic outcome. Generics legislation had a major impact on the industry, providing incentives for innovation and a race to market. The time during which R&D costs could be recouped was drastically curtailed, putting upward pressure on prices. By the end of the 1970s generic entrants and more stringent controls on clinical trials had led to substantial increases in R&D spending.